Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | DCC-3009 |
Trade Name | |
Synonyms | DCC3009|DCC 3009 |
Drug Descriptions |
DCC-3009 is a KIT inhibitor with activity against exon 9 and 11 mutations, as well as mutations in exons 13, 14, 17, and 18, potentially resulting in decreased tumor growth (Cancer Res (2023) 83 (7_Supplement): 4033). |
DrugClasses | KIT Inhibitor 57 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
DCC-3009 | DCC-3009 | 2 | 1 |